Results 111 to 120 of about 1,487 (134)
Some of the next articles are maybe not open access.
Lebrikizumab Monotherapy for the Treatment of Moderate to Severe Atopic Dermatitis
The Journal of Allergy and Clinical Immunology: In Practice, 2023Nikki, Kimura, Punita, Ponda
openaire +2 more sources
<p>Therapeutic Potential of Lebrikizumab in the Treatment of Atopic Dermatitis</p>
Journal of Asthma and Allergy, 2020Vivian Y Shi +2 more
exaly
Lebrikizumab safe in adolescents and adults with atopic dermatitis
Reactions Weekly, 2023openaire +1 more source
Results from 1 year of treatment with lebrikizumab for atopic dermatitis
British Journal of Dermatology, 2023openaire +2 more sources
Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids
Journal of Allergy and Clinical Immunology, 2013Joseph Arron +2 more
exaly
Lebrikizumab for Moderate-to-Severe Atopic Dermatitis. Reply.
The New England journal of medicine, 2023Jonathan I, Silverberg +2 more
openaire +1 more source